The trial will focus on evaluating the Kiva System against Medtronic’s Kyphon Balloon Kyphoplasty. The trial enrolled 300 patients and is being conducted to support a subsequent 510(k) filing for market clearance from the U.S. Food and Drug Administration.
More Articles on Orthopedic Devices:
Medtronic Receives 510(k) Approval for Orthopedic Sealer
10 Milestones for Spine Implants & Device Companies
Zimmer Net Sales Reaches $1.1B, Down 1.1%
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.